VAERS reports by lot

GSK Hepatitis B lot AHABB140AA: VAERS reports

30 VAERS reports list lot AHABB140AA as a GSK Hepatitis B vaccine, received between 2008-06-23 and 2010-11-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
30
Reports
33%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1721%
Dermatological (non-injection-site)1114%
General / Systemic (non-local)1114%
Injection-site / Local reaction1114%
Allergic / Anaphylactic911%
Gastrointestinal810%
Cardiac / Cardiovascular56%
Musculoskeletal45%
Psychiatric / Neuropsychiatric34%
Respiratory22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Oregon4
Texas4
North Carolina3
Wyoming3
California2
Missouri2
Utah2
Indiana2
New York2
Arizona1
Washington1
West Virginia1

Reports by month received

2008-061
2008-072
2008-081
2008-093
2008-102
2008-113
2008-121
2009-012
2009-031
2009-041
2009-061
2009-091
2009-122
2010-022
2010-034
2010-051
2010-061
2010-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.